Gritstone bio, Inc. Profile Avatar - Palmy Investing

Gritstone bio, Inc.

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid t…

Biotechnology
US, EmeryVille [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Gritstone bio, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Gritstone bio, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Gritstone bio, Inc..

End of GRTS's Analysis
CIK: 1656634 CUSIP: 39868T105 ISIN: US39868T1051 LEI: - UEI: -
Secondary Listings
GRTS has no secondary listings inside our databases.